This house believes that all patients should be treated with VEGF inhibitors plus chemotherapy in first line and beyond progression

Date 23 May 2014
Event ESMO Preceptorship on Colorectal Cancer 2014
Session Session 6 - Metastatic colorectal cancer I
Presenter Jean-Yves Douillard
Authors J. Douillard
  • Nantes-Saint-Herblain/FR